Register / Log In

Compounding association urges women's health groups to reveal ties with Wyeth

Stung by the warning letter the Food & Drug Administration has issued to seven pharmacies over their compounding of bio-identical hormones, the International Academy of Compounding Pharmacists (IACP) has just issued a press release. The release states that two groups that are "supposedly independent women's health organizations" have actually received funding from Wyeth, which had petitioned FDA to take action against bio-identical hormones. IACP urged the North American Menopause Society (NAMS) and the American Association of Clinical Endocrinologists (AACE) to disclose their financial ties with Wyeth. What is NAMS' and AACE's response? Wulf Utian, M.D., Ph.D., executive director of NAMS, said, "NAMS has never denied receiving income for specific services from dozens of companies, including Wyeth. NAMS maintains a firewall between its scientific endeavors and its sources of income. NAMS remains supportive of the FDA in their actions, despite the slander campaign now being undertaken by (the compounding) industry to preserve its market." AACE was contacted for a reaction, but it did not respond at press time.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, click here.


A new Office of Inspector General report recommends that iCare refund Medicare more than $8 million for improperly filing claims for test strips and lancets.

State-run drug price comparison sites hampered by missing data, according to a study by Center for Studying Health System Change.